Search for Andrew Witty and
  1. April 7, 2014

    Reform of pharma practices should go wider than GSK

    Two cases do not make an epidemic. But it is still serious for GlaxoSmithKline that allegations of bribery have surfaced in...

  2. April 1, 2014

    Drugmakers learn to blend commerce with philanthropy in Africa

    Africa has rarely been a source of good publicity for big pharma. But two events this week suggest the drugs industry is...

  1. February 5, 2014

    GlaxoSmithKline sticks with bet on emerging markets

    GlaxoSmithKline, the UK drugmaker, will press ahead with its big bet on emerging markets, despite turmoil in its scandal-hit...

  2. December 17, 2013

    GSK China probe flags up wider concerns

    Unshaven and dressed in a blue and grey striped T-shirt, Liang Hong looked nondescript on screen. But his words, broadcast...

  3. December 16, 2013

    GSK scraps sales rep targets after scandal

    GlaxoSmithKline is to scrap individual sales targets for its commercial staff as it seeks to repair its image and reform...

  4. December 3, 2013

    Detained couple’s son in call to GSK boss

    The son of a British fraud investigator detained in Shanghai has called on the head of GlaxoSmithKline, the UK drugs company...

  5. December 3, 2013

    David Cameron defends GSK during China trip

    David Cameron has risked angering the Chinese government by launching a robust defence of GlaxoSmithKline as the UK drug...

  6. December 2, 2013

    Spotlight on Cameron’s China delegation

    David Cameron has taken a business delegation of 127 executives with him to China, most of whom will have very little...

  7. November 24, 2013

    SMEs and business schools need closer working links

     Lord Digby Jones – the former head of the CBI, the employers’ body – once said that when it comes to business schools,...

  8. October 23, 2013

    GSK China sales plummet 60% since scandal

    GlaxoSmithKline’s medicine and vaccine sales in China have dropped 61 per cent since the summer, following a high-profile...

  9. October 15, 2013

    Ministers urged to tap university research

    A leading industrialist has urged ministers to commit at least £1bn in the next parliament to university-led projects that...

  10. September 23, 2013

    GlaxoSmithKline China sales face growing pressure

    Sales of GlaxoSmithKline’s medicines in China are thought to have dropped 30 per cent since officials accused the UK...

  11. July 24, 2013

    GSK: in need of a Chinese remedy

    Scandals are, by nature, vague and confusing things. Are things as bad as they look? How long until the fog clears? Since...

  12. July 24, 2013

    Bribery built into the fabric of Chinese healthcare system

    In a hospital on the outskirts of Beijing, the hallway outside the main nurses’ station was unusually empty on Wednesday....

  13. July 24, 2013

    UK call to step up east-west fight against crime

    Britain has called on China to accelerate plans to share information in criminal investigations in a sign of a growing drive...

  14. July 22, 2013

    GSK’s mea kinda culpa is a first step to redemption

    GlaxoSmithKline is wise to admit that staff may have broken Chinese bribery laws. When big companies stonewall during a...

  15. MBA blog

    July 22, 2013

    Inspiration from an entrepreneur

    In late spring we were fortunate to attend the third and final lecture in the Pears Business School Lecture Series. The...

  16. July 15, 2013

    GSK probe shows the peril of operating in corrupt markets

    Old Asia hands doubt that police action against executives of GlaxoSmithKline in China marks the dawning of a new era of...

  17. July 15, 2013

    GSK is test case in China’s rules laboratory

    Hundreds of millions of dollars of allegedly improper payments under review by the Chinese police. Evidence of sexual...

  18. July 4, 2013

    Pharma price wars patently transcend all ideologies

    Police in Changsha, China, have accused GlaxoSmithKline staff of “economic crimes”. The charge sounds distinctly Maoist, as...

  19. April 24, 2013

    GSK to sell off Lucozade and Ribena

    GlaxoSmithKline is to sell off its Lucozade and Ribena drinks business by the end of this year and place its off-patent...

  20. April 8, 2013

    Growth prospects seen in university research

    Sir Andrew Witty is to come up with a plan on how British universities might go about engaging more with local businesses in...

  21. March 10, 2013

    CEOs applaud protection of overseas aid

    David Cameron’s decision to protect Britain’s overseas aid budget has been praised by Britain’s leading business figures,...

  22. February 6, 2013

    GSK unveils European restructuring plans

    GlaxoSmithKline said it was considering the sale of its Ribena and Lucozade drinks brands to refocus on faster-growing...

  23. October 31, 2012

    GSK to raise dividend despite sales drop

    GlaxoSmithKline pledged further dividend increases and share buybacks despite a drop in earnings. The earnings fall, deeper...

  24. October 28, 2012

    GSK starts search for new chairman

    GlaxoSmithKline has begun the hunt for a successor to Sir Christopher Gent, who is expected to step down as chairman within...

  25. October 4, 2012

    Raids seek to clamp down on fake drugs

    At 7am on a rainy Manchester morning, police in protective jackets surround an address on a council estate in the city’s...

  26. July 31, 2012

    Healthcare: Into the cortex

    Imagine a pharmaceutical company 20 or 30 years from now. Moving beyond conventional drugs that interact biochemically with...

  27. July 25, 2012

    GSK hit by price cutting in Europe

    GlaxoSmithKline cut its sales forecast to flat for the full year against a backdrop of intensifying European price cuts, as...

  28. July 16, 2012

    Human Genome takes its medicine

    At the end of last week, Thomas Watkins, chief executive of Human Genome Sciences, made the call he had been hoping to...

  29. July 6, 2012

    GSK ills symptomatic of wider malaise

    More than a year after Andrew Witty was selected to run GlaxoSmithKline, the executive director of marketing for its biggest...

  30. July 6, 2012

    Barclays shows watchdogs need more teeth

    Is there something rotten in the state of Britain plc? Much of the blame for the behaviour of the traders at Barclays who...

  31. July 3, 2012

    GlaxoSmithKline: bad medicine

    Funny how the public and politicians react to corporate misdeeds. As the British throw a fit over interest rate manipulation...

  32. FT Alphaville

    July 2, 2012

    How to sound contrite (as a potential kid poisoner)

    There’s a lesson here for Bob and others in banking bother. It comes from Andrew Witty, chief executive of GlaxoSmithKline,...

  33. June 25, 2012

    EU warned over medicine price cuts

    Europe risks losing its global influence in pharmaceuticals to the US and Asia unless governments shift away from price cuts...

  34. May 16, 2012

    Pharma reform should focus on R&D not CEOs

    From Mr Peter Keeling. Sir, Andrew Jack’s spotlight on Andrew Witty (“Loneliness of long-distance runner”, May 12) describes...

  35. May 11, 2012

    Witty targets HGS with first hostile bid

    Henry Wellcome, the US immigrant who laid the foundations 130 years ago for the UK-based pharmaceutical group...

  36. May 9, 2012

    GSK’s knowledge key to hostility

    “Roses are red, violets are blue. It’s curtains for you and your strategic review.” Clinton Cards, whose main supplier has...

  37. May 6, 2012

    Pharma tries to avoid falling off ‘patent cliff’

    For four years Chris Viehbacher has been bracing himself for a nasty turn. Since being appointed Sanofi’s chief executive in...

  38. April 25, 2012

    GSK hit by sluggish emerging market sales

    GlaxoSmithKline is to buy back up to £2.5bn in shares this year and increase its dividend despite first-quarter results...

Search for Andrew Witty and